DOI QR코드

DOI QR Code

Guillain-Barré Syndrome after Lung Transplantation in the Immediate Postoperative Period: Case Report

  • Gu, Byung Mo (Department of Thoracic and Cardiovascular Surgery, Hallym University Sacred Heart Hospital) ;
  • Ko, Ho Hyun (Department of Thoracic and Cardiovascular Surgery, Hallym University Sacred Heart Hospital) ;
  • Lee, Hong Kyu (Department of Thoracic and Cardiovascular Surgery, Hallym University Sacred Heart Hospital) ;
  • Ra, Yong Joon (Department of Thoracic and Cardiovascular Surgery, Hallym University Sacred Heart Hospital) ;
  • Lee, Hee Sung (Department of Thoracic and Cardiovascular Surgery, Hallym University Dongtan Sacred Heart Hospital) ;
  • Kim, Hyoung Soo (Department of Thoracic and Cardiovascular Surgery, Hallym University Sacred Heart Hospital)
  • Received : 2020.06.11
  • Accepted : 2020.10.04
  • Published : 2021.10.05

Abstract

A 58-year-old man, incapable of maintaining oxygen saturation with mechanical ventilation, was admitted to our hospital for veno-venous extracorporeal membrane oxygenation (ECMO) treatment. He was diagnosed with acute respiratory distress syndrome (ARDS) due to influenza A pneumonia. His condition stabilized with antibiotics and steroid administration, but weaning from ECMO failed due to post-infectious pulmonary sequelae. On day 84 after admission, he underwent bilateral lung transplantation. In the postoperative phase, he did not regain consciousness even after discontinuation of sedatives for 3 days. However, spontaneous pupillary reflex and eye movements were preserved, while communication and upper and lower limb movements were affected. The nerve conduction study was diagnostic of Guillain-Barré syndrome. He was managed with intravenous immunoglobulins and plasmapheresis. Mild recovery of the facial muscles was seen, but he died 24 days post-surgery due to progressive ARDS and sepsis.

Keywords

References

  1. Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011;36:123-33. https://doi.org/10.1159/000324710
  2. Hughes RA, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barre syndrome: a systematic review. Brain 2007;130(Pt 9):2245-57. https://doi.org/10.1093/brain/awm004
  3. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990;27 Suppl:S21-4. https://doi.org/10.1002/ana.410270707
  4. Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Guillain-Barre syndrome following allogeneic bone marrow transplantation. Neurology 1997;49:1711-4. https://doi.org/10.1212/WNL.49.6.1711
  5. El-Sabrout RA, Radovancevic B, Ankoma-Sey V, van Buren CT. Guillain-Barre syndrome after solid organ transplantation. Transplantation 2001;71:1311-6. https://doi.org/10.1097/00007890-200105150-00023
  6. Sharma NS, Wille KM, Hoopes CW, Diaz-Guzman E. Acute demyelinating polyneuropathy after lung transplantation: Guillain-Barre syndrome or tacrolimus toxicity? Case Rep Transplant 2014;2014:685010.
  7. Meena P, Bhargava V, Rana DS, et al. Tacrolimus-associated Guillain-Barre syndrome. Am J Ther 2020 Feb 20 [Epub]. https://doi.org/10.1097/MJT.0000000000001096.
  8. Bechstein WO. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000;13:313-26. https://doi.org/10.1111/j.1432-2277.2000.tb01004.x
  9. Boon M, Dennesen PJ, Veldkamp RF. A rare stress cardiomyopathy in a patient with Guillain-Barre syndrome. Neth J Med 2016;74:86-8.